[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3703 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 3703

 To direct the Comptroller General of the United States to conduct and 
complete a review examining the efforts of the Secretary of Health and 
Human Services to ensure that the United States is prepared to rapidly 
produce certain medical countermeasures in the event of a public health 
                   emergency, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 25, 2023

   Mr. Latta (for himself and Ms. Kelly of Illinois) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
 To direct the Comptroller General of the United States to conduct and 
complete a review examining the efforts of the Secretary of Health and 
Human Services to ensure that the United States is prepared to rapidly 
produce certain medical countermeasures in the event of a public health 
                   emergency, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Helping Evaluate Appropriate 
Logistical Infrastructure for National Government Response Act of 
2023'' or the ``HEALING Response Act of 2023''.

SEC. 2. GAO REVIEW OF HHS EFFORTS TO ENSURE RAPID PRODUCTION OF CERTAIN 
              MEDICAL COUNTERMEASURES IN CASE OF A PUBLIC HEALTH 
              EMERGENCY.

    (a) In General.--Not later than 1 year after the date of the 
enactment of this Act, the Comptroller General of the United States 
shall conduct and complete a review examining the efforts of the 
Secretary of Health and Human Services to ensure that the United States 
is prepared to rapidly produce qualified countermeasures (as defined in 
section 319F-1 of the Public Health Service Act (42 U.S.C. 247d-6a)) in 
the event of a public health emergency declared under section 319 of 
the Public Health Service Act (42 U.S.C. 274d).
    (b) Contents.--The review conducted under subsection (a) shall 
include a review of--
            (1) the efforts described in such subsection, including the 
        Secretary's efforts to transition from the Centers for 
        Innovation and Advanced Drug Manufacturing program to any new 
        efforts, including the National Biopharmaceutical Manufacturing 
        Partnership and Industrial Base Expansion Connect;
            (2) the progress made toward the implementation of such 
        efforts; and
            (3) the planning within the Department of Health and Human 
        Services to assess risks and challenges associated with 
        advanced development and manufacturing of qualified 
        countermeasures.
    (c) Report to Congress.--Not later than 1 year after completing the 
review under subsection (a), the Comptroller General of the United 
States shall submit to the Congress a report containing--
            (1) the results of the review; and
            (2) the Comptroller General's recommendations for ensuring 
        that the United States is prepared to rapidly produce qualified 
        countermeasures in the event of a public health emergency.
                                 <all>